Over-the-Counter Drugs Market In-Depth Analysis with Booming Trends Supporting Growth Till 2026
The global
over-the-counter drugs market is highly competitive, owing to
increasing adoption of personal healthcare and self-medication due to
rising awareness among the people regarding health precautions and
basic drug knowledge. Under such conditions, the competitors
experience performance pressure in terms of pricing. Market players
are thus focusing on development of OTC drugs in cost-effective way
that will help to cater price-sensitive customers, in turn,
significantly maintain and subsequently increase profit margins,
especially in emerging economies.
The top 10
players operating in the global over-the-counter drugs market
include:
Pfizer, Inc.,
Novartis AG
GlaxoSmithKline Plc
Bayer AG
Sanofi
Glenmark
Pharmaceuticals
Merck KGaA
Teva Pharmaceuticals
Johnson &
Johnson Services, Inc.
Boehringer Ingelheim
For More Details
Download the PDF brochure:
Pfizer, Inc.
- Pfizer, Inc. is a global leading manufacturer and distributor of
over-the-counter drugs, managing its commercial operation through two
major business segments namely, Pfizer Innovative Health and Pfizer
Essential Health. OTC drugs contribute to a major part of Innovative
Health Segment, comprising annual revenue of US$ 29,197 million in
2016.
Novartis AG -
Novartis AG, is widely known for its research, development,
manufacturing, and marketing of healthcare products across the globe.
Novartis operates its drugs business through two major operating
channels Innovative Medicine and Drugs manufactured by Sandoz which
is a subsidiary of Novartis, has contributed to positioning the
company as one of the top players in global Over-the-counter drugs
market.
GlaxoSmithKline
Plc - GlaxoSmithKline, one of the renowned giant in
pharmaceutical industry and over-the-counter drugs market is a global
science-led company headquartered in Europe, which develops and
manufactures pharmaceutical products, including vaccines,
health-related consumer products, and over-the-counter medicines. The
consumer healthcare business of GlaxoSmithKline is operated through
its subsidiary named GlaxoSmithKline Consumer Healthcare Holdings
Ltd. the subsidiary is split into two equal businesses, namely
Over-the-counter Medicines and Fast Moving Consumer Goods (FMCG),
across four major categories of Oral Health, Wellness, Skin Health,
and Nutrition.
Bayer AG -
Bayer AG is a global life science company that has a history of over
150 years in areas of healthcare and agriculture. The company
operates its business through four major segments namely,
Pharmaceuticals, Consumer Health, Crop Science, and Animal Health.
Over-the-counter drugs contribute to a major revenue share of the
consumer health segment, which accounted for US$ 7,179.19 million in
2016.
Sanofi -
Sanofi is a global life science company based in France (Europe) that
is aimed towards improving healthcare access to people. The company
operates its business through two major segments namely,
Pharmaceuticals and Vaccines. The company operates its
over-the-counter business as a part of a major business segment named
Consumer Healthcare (CHC). Sanofi focuses on partnerships and
acquisitions to expand its consumer healthcare business.
Following is the
Impact Analysis of the strategies employed by the competitors and its
impact on the revenues and sales in the global over-the-counter drugs
market.
Click To
Read More On
Over-the-Counter Drugs Market
Also, Coherent
Market Insights has a proprietary database of pipeline biologics and
biosimilars, called PHASE-XS. This database provides analytical data
in addition to the clinical information of ongoing trials for
biologics and biosimilars. An amalgamation of more than 30
parameters, PHASE-XS helps biotechnology and pharmaceutical companies
to analyze the market trend, competition, and market potential. For
more information or to access this database, kindly click on the
below link or contact at sales@coherentmarketinsights.com
About
Coherent Market Insights:
Coherent Market
Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis,
consulting services, and competitive analysis through various
recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Comments
Post a Comment